Nirsevimab is effective for protecting infants against respiratory syncytial virus (RSV)-associated lower respiratory tract ...

The rate of atrial fibrillation was also higher in RSV patients, although it depended on preexisting heart conditions and ...

Professor Margie Danchin addresses declining childhood vaccination rates and vaccine hesitancy through trust-building ...

The global infectious disease treatment market is projected to grow from $72.5 billion in 2025 to $101 billion by 2030, with ...

Modern medicine is largely reactive—treating illness only after symptoms emerge. But a new study from the Research Institute ...

British pharmaceutical giant GSK Plc (NYSE:GSK) shares rose on Wednesday after reporting second-quarter results that ...

In a bid to enhance paediatric healthcare and improve awareness among medical professionals, Gurgaon-based Medanta Hospital, in collaboration with the Indian Academy of Pediatrics (IAP) Guwahati City ...

US health secretary Robert F Kennedy Jr’s changes to federal vaccine policy are prompting medical organisations and several ...

Wealthy Chinese consumers are likely to spend three times more than their peers on post-retirement healthcare over the next ...

Investing.com -- GSK (LON: GSK) on Wednesday raised its full-year earnings guidance after posting a 35% rise in ...